ロード中...
Identification of Compounds that Inhibit the Kinase Activity of Leucine-rich Repeat Kinase 2
Mutations in leucine-repeat rich kinase-2 (LRRK2) are the most common known cause of late-onset Parkinson's disease. In this study, a novel system to purify active recombinant LRRK2 expressed in mammalian cells was generated. This recombinant enzyme was used to characterize the specificity of L...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2008
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2633649/ https://ncbi.nlm.nih.gov/pubmed/19027715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2008.11.048 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|